Key Market Segments
By Product & Service
-
Products
-
Instruments
-
Consumables
-
Software
-
-
Services
By Type
-
Single-cell Multiomics
-
Bulk Multiomics
By Platform
-
Genomics
-
Transcriptomics
-
Proteomics
-
Metabolomics
-
Integrated Omics Platforms
By Application
-
Cell Biology
-
Oncology
-
Neurology
-
Immunology
By End Use
-
Academic and Research Institutes
-
Pharmaceutical & Biotechnology Companies
-
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
-
US
-
Canada
-
Mexico
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Poland
-
Turkey
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Singapore
-
Australia
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g., Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Ans: Future multiomics market trends point toward increasing adoption of single-cell multiomics, AI-driven data interpretation, and cloud-based omics integration platforms. Expansion of applications in microbiome research, early cancer detection, and chronic disease monitoring will further increase demand.
Ans: North America, particularly the U.S., leads in mRNA raw material supply due to strong manufacturing infrastructure and R&D capabilities. Europe, with major contributions from Germany and Switzerland, follows closely. Asia Pacific, led by China and India, is rapidly expanding due to growing domestic manufacturing and government support for mRNA-based vaccine development.
Ans: Key players in the mRNA raw materials supply chain include Thermo Fisher Scientific, Merck KGaA, Danaher Corporation (Cytiva), Agilent Technologies, BioNTech SE, TriLink BioTechnologies, Echelon Biosciences, New England Biolabs, Promega Corporation, and GenScript Biotech.
Ans: The multiomics market growth is being driven by increasing demand for personalized medicine, rapid advancements in next-generation sequencing and mass spectrometry technologies, and growing integration of AI in omics data analysis.
Ans: The multiomics market size was valued at USD 2.86 billion in 2024 and is projected to reach USD 8.97 billion by 2032, growing at a CAGR of 15.38% during the forecast period from 2025 to 2032.
Get in touch
